Janus Henderson Group’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-35,253	Closed	-$86.2K	–	2454
2025 Q2	$86.2K	Sell	35,253 -3,255,590	-99%	-$16.5M	﹤0.01%	2398
2025 Q1	$25M	Sell	3,290,843 -713,196	-18%	-$7.05M	0.01%	520
2024 Q4	$50.3M	Buy	4,004,039 +2,106,699	+111%	+$31.7M	0.03%	388
2024 Q3	$35.1M	Sell	1,897,340 -1,021,738	-35%	-$20.9M	0.02%	461
2024 Q2	$62.8M	Buy	2,919,078 +313,062	+12%	+$7.19M	0.03%	336
2024 Q1	$70.2M	Buy	2,606,016 +1,656,111	+174%	+$47M	0.04%	323
2023 Q4	$28.4M	Buy	949,905 +47,810	+5%	+$1.06M	0.02%	478
2023 Q3	$18.5M	Buy	902,095 +874,999	+3,229%	+$15.9M	0.01%	548
2023 Q2	$538K	Buy	27,096 +66	+0.2%	+$1.33K	﹤0.01%	1933
2023 Q1	$463K	Buy	27,030 +13,380	+98%	+$262K	﹤0.01%	2064
2022 Q4	$267K	Buy	+13,650	New	+$251K	﹤0.01%	2024
2022 Q1	–	Sell	-15,957	Closed	-$348K	–	2696
2021 Q4	$348K	Sell	15,957 -1,213,541	-99%	-$33.1M	﹤0.01%	2119
2021 Q3	$36.8M	Sell	1,229,498 -5,991	-0.5%	-$218K	0.02%	641
2021 Q2	$54.7M	Sell	1,235,489 -5,827	-0.5%	-$253K	0.02%	547
2021 Q1	$55.1M	Sell	1,241,316 -35,994	-3%	-$1.98M	0.03%	519
2020 Q4	$70M	Buy	1,277,310 +1,199,043	+1,532%	+$43.7M	0.03%	458
2020 Q3	$1.79M	Buy	78,267 +4,698	+6%	+$116K	﹤0.01%	1071
2020 Q2	$1.54M	Buy	73,569 +5,579	+8%	+$101K	﹤0.01%	1066
2020 Q1	$948K	Buy	+67,990	New	+$1.35M	﹤0.01%	1106

Other funds holding RCKT